Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease

Annals of Saudi Medicine

Volumn 24, Issue 5, 2004, Pages 332-336

  Panhotra, B R ^a   Saxena, A K ^a   Al Arabi Al Ghamdi, Ali M ^a  

^a KING FAHAD HOSPITAL   (Saudi Arabia)

Author keywords

Ciprofloxacin; Fluoroquinolones; Microbial drug resistance; Nalidixic acid; Non typhoidal Salmonella; Saudi Arabia

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE DIARRHEA; ANIMAL FOOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DIFFUSION; DRUG USE; FECES ANALYSIS; HOSPITAL PATIENT; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; SALMONELLA; SALMONELLOSIS; SAUDI ARABIA; SEROTYPE; STRAIN DIFFERENCE;

EID: 5744229802     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2004.332     Document Type: Article

References (33)

1. Threlfall EJ, Frost JA, Ward LR, Rowe B. Increasing spectrum of resistance in multiresistant Salmonella typhimurium. Lancet. 1996;347:1053-1054.
2. World Health Organisation. Emerging food borne diseases. Fact Sheet 2002; No.124.
3. Panhotra BR, Agarwal KC. Drug resistance in Salmonella typhimurium. Trop Geogr Med. 1982;34:277-279.
4. Agarwal KC, Panhotra BR, Garg RK, Verma AD, Ayyagri A, Mahanta J. Drug resistance in Salmonella isolated at Chandigarh. Antonie Van Leeuwenhoek. 1980;46: 383-390.
5. Threlfall JE, Fisher IST, Berghold C, Gerner-Smidt P, Tschape H, Cormican M. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of Salmonellosis in humans in Europe in 2000: Results of international surveillance. Euro Surveill. 2003;8: 41-45.
6. Threlfall EJ, Ward LR, Skinner JA, Rowe B. Increase in multiple antibiotic resistance in non-typhoidal Salmonella from human in England & Wales: Comparison of data of 1994 and 1996. Microb Drug Resist. 1997;3:263-266.
7. Chruchaga S, Echeita A, Aladuena A, Garcia-pena J, Frias N, Usera MA. Antimicrobial resistance in Salmonella from humans, food and animals in Spain. Antimicrob Chemother. 2001;47:315-321.
8. Helms M, Vastrup P, Gerner-Smidt P, Mølbak K. Excess mortality associated with antimicrobial drug resistant Salmonella typhimurium. Emerg Infect Dis. 2002;8:490-496.
9. Nakaya H, Yasuhara A, Yoshimura K, Oshihoi Y, Izumiya H, Watanabe H. Life-threatening infantile diarrhea from fluoroquinolone resistant Salmonella enterica typhimurium with mutation in both gyrA and parC. Emerg Infect Dis. 2003;9:255-257.
10. Aspergilla MO, Smego RA, Scott LK. Quinolone antibiotics in treatment of Salmonella infections. Rev Infect Dis. 1990; 12:873-889.
11. Mølbak K, Garner-Smidt P, Wegener HC. Increasing quinolone resistance in Salmonella enterica serotype enteritidis. Emerg Infect Dis. 2002;8:514-515.
12. Mølbak K, Baggesen DL, Aarestrup FM, Ebbesens JM, Engberg J, Frydendahl K. An outbreak of multi drug resistant quinolone resistant Salmonella typhimurium. N Engl J Med. 1999;341:1420-1425.
13. Frost JA, Kellehr A, Rowe B. Increasing resistance in Salmonella in England & Wales 1991-1994. J Antimicrob Chemother. 1996;37:85-96.
14. Hakanen A, Slitonen A, Kotlilanen P, Huovinen P. Increasing fluoroquinoline resistance in Salmonella serotypes in Finland during 1995-1997. J Antimicrob Chemother. 1999;43:145-148.
15. Threlfall EJ, Ward LR, Rowe B. Multiresistant Salmonella typhimurium DT104 and Salmonella bacteremia. Lancet. 1998; 352:287-288.
16. Wall PG, Morgan D, Landen K, Ryan M, Griffin M, Threlfall EJ. A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT 104 in England & Wales. Commun Dis Rep CDR Rev. 1994;4:130-135.
17. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 6th ed. NCCLS document M2-A6. Wyne, PA, USA:1997.
18. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. 12th informational supplement. NCCLS document, M100-Sl2. Wyne, PA, USA: 2002.
19. Cohen ML, Tauxe RV. Drug resistant Salmonella in United States: An epidemiologic perspective. Science. 1986;234:964-969.
20. Ryan CA, Nickels MK, Hargrett-Bean NT, Potter ME, Endo T, Mayer L. Massive outbreak of antimicrobial Salmonellosis traced to pasteurized milk. JAMA. 1987;258:3269-3274.
21. Holmberg SO, Osterholm MT, Senger KA, Cohen ML. Drug resistant Salmonella from animals fed antimicrobials. N Engl J Med. 1984; 311:617-622.
22. Heriksted H, Hayes P, Mokhtar M, Fracaro ML, Threlfall EJ, Angulo FJ. Emergence of quinolone resistant Salmonella in United States. Emerg Infect Dis. 1997;3:371-372.
23. Frost JA, Kelleher A, Rowe B. Increasing ciprofloxacin resistance in Salmonella in England & Wales 1991-1994. J Antimicrob Chemother. 1996;37:85-91.
24. Piddock LJ, Ricci V, McLaren I, Griggs DJ. Role of mutation in the gyrA and parC genes of Nalidixic acid resistant Salmonella serotypes isolated from animals in the United Kingdom. J Antimicrob Chemother. 1998; 41:635-641.
25. Hakanen A, Kotlainin P, Huovinen P, Helenius H, Siitonen A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from South East Asia. Emerg Infect Dis. 2001;7:996-1003.
26. Smith KE, Berser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH. Quinolone resistant Campylobacter jejunum infection in Minnesota 1992-1998. N Engl J Med. 1999;340:1525-1532.
27. Saenz Y, Zarazaga M, Lantero M, Gastaures MJ, Baquero F, Torres C. Antibiotic resistance in Campylobacter strains isolated from animals, food & humans in Spain 1997-1998. Antimicrob Agent Chemother. 2000;44: 267-271.
28. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in-vitro and in-vivo selected mutants of Salmonella spp suggests a counter selection of highly fluoroquinolone resistant strains in the field. Antimicrob Agent Chemother. 1999;43:2131-2137.
29. Ronald AR, Turck M, Petersdrof RC. A critical evaluation of Nalidixic acid in urinary tract infections. N Engl J Med. 1966;275:1081-1089.
30. Hoge CW, Bodhidatta L, Tungtaem C, Echeverria P. Emergence of Nalidixic acid resistant Shigella dysenteriae 1 in Thailand: Outbreak associated with consumption of a coconut milk dessert. Int J Epidemiol. 1995; 24;1228-1236.
31. Panhotra BR, Bhavana D. Resistant Shigella dysenteriae 1. Lancet.1983;ii:1420.
32. Panhotra BR, Bhavana D, Sharma PL. Nalidixic acid resistant Shigella dysenteriae 1. Lancet. 1985;i:763.
33. Gosh AR, Sugunan AP, Seghal SC, Bhardwaj AP. Emergence of nalidixic acid resistance Shigella sonnei in acute diarrhea patients on Andaman and Nicobar Island, India. Antimicrob Agents Chemother. 2003;47;1483-1484.